Retained placenta can be defined as lack of placental expulsion within 30 minutes of delivery of an infant. it is more common in preterm. Retained Placenta can lead to massive PPH and increase maternal morbidity and mortality.
Emergencies that occur in pregnancy or during or after labor and delivery.
main emergencies are
Ectopic Pregnancy
Uterine Inversion
Obstetrical Shock
Cord Prolepses
Amniotic Fluid Embolism
Postpartum Hemorrhage
A serious pregnancy complication in which the placenta detaches from the womb (uterus).
Placental abruption occurs when the placenta detaches from the inner wall of the womb before delivery. The condition can deprive the baby of oxygen and nutrients.
Symptoms include vaginal bleeding, stomach pain and back pain in the last 12 weeks of pregnancy.
Depending on the degree of placental separation and how close the baby is to full-term, treatment may include bed rest or a Caesarean (C-section).
AMNIOINFUSION--
definition-An amnioinfusion is a technique of instilling an isotonic fluid {such as a normal saline or lactated ringer’s solution} into the amniotic cavity during labor to relieve umbilical cord compression and alleviate fetal distress from severe prolonged variable decelerations in the presence of oligohydramnios.
INDICATIONS
Fetal heart rate abnormalities
APGAR scores for those with low scores
Asphyxia during time of birth
Decreasing the rates of cesarean birth related with FHR problem
PROCEDURE
The amnio infusion procedure involves the use of an intrauterine pressure catheter (IUPC), or a single or double lumen type of IUPC.
The IUPC has been designed to attain an accurate monitoring of uterine contractions among women in the intrapartum period.
It has a special port from which the saline fluid or lactated ringer’s solution is being injected, passing through the tubing and going its way into the uterus.
An IUPC is inserted through standard technique once the membranes ruptures, and then it is attached to intravenous extension tubing. If IUPC is not available, a pediatric nasogastric tube can be used instead.
Lactated ringer’s solution without dextrose is infused into the amniotic cavity; normal saline can be an acceptable fluid alternative
Assisting Physician with Amnioinfusion
Explain the procedure to the patient.
Assist in dorsal recumbent position. Assist with draping and exposing vaginal area.
Connect IUPC tubing to IV fluid, flush
Connect the catheter to the monitor cable
Assist physician with insertion of double lumen IUPC and connect IV tubing to the amnioport to begin amnioinfusion.
Oligohydramnios by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
• Oligohydramnios refers to amniotic fluid volume that is less than expected for gestational age. It is typically diagnosed by ultrasound examination and may be described qualitatively (eg, reduced amniotic fluid volume) or quantitatively (eg, amniotic fluid index ≤5 cm, single deepest pocket <2 cm).
• Oligohydramnios may be idiopathic or have a maternal, fetal, or placental cause The fetal prognosis depends on several factors, including the underlying cause, the severity (reduced versus no amniotic fluid), and the gestational age at which oligohydramnios occurs. Because an adequate volume of amniotic fluid is critical to normal fetal movement and lung development and for cushioning the fetus and umbilical cord from uterine compression, pregnancies complicated by oligohydramnios from any cause are at risk for fetal deformation, pulmonary hypoplasia, and umbilical cord compression.
• Oligohydramnios is associated with an increased risk for fetal or neonatal death, which may be related to the underlying cause of the reduced amniotic fluid volume or due to sequelae of the reduced amniotic fluid volume.
• This topic will discuss issues related to oligohydramnios. Methods of amniotic fluid volume assessment are reviewed separately.
• Oligohydramnios occurs when the amniotic fluid is < 5th centile for gestational age.
• The most common causes are premature rupture of membranes (often missed by the mother) and placental insufficiency, however structural abnormalities such as renal agenesis should be considered.
• Prognosis is linked to gestation at diagnosis and likely development of pulmonary hypoplasia and premature delivery.
• Treatment is by optimising gestation of delivery
Retained placenta can be defined as lack of placental expulsion within 30 minutes of delivery of an infant. it is more common in preterm. Retained Placenta can lead to massive PPH and increase maternal morbidity and mortality.
Emergencies that occur in pregnancy or during or after labor and delivery.
main emergencies are
Ectopic Pregnancy
Uterine Inversion
Obstetrical Shock
Cord Prolepses
Amniotic Fluid Embolism
Postpartum Hemorrhage
A serious pregnancy complication in which the placenta detaches from the womb (uterus).
Placental abruption occurs when the placenta detaches from the inner wall of the womb before delivery. The condition can deprive the baby of oxygen and nutrients.
Symptoms include vaginal bleeding, stomach pain and back pain in the last 12 weeks of pregnancy.
Depending on the degree of placental separation and how close the baby is to full-term, treatment may include bed rest or a Caesarean (C-section).
AMNIOINFUSION--
definition-An amnioinfusion is a technique of instilling an isotonic fluid {such as a normal saline or lactated ringer’s solution} into the amniotic cavity during labor to relieve umbilical cord compression and alleviate fetal distress from severe prolonged variable decelerations in the presence of oligohydramnios.
INDICATIONS
Fetal heart rate abnormalities
APGAR scores for those with low scores
Asphyxia during time of birth
Decreasing the rates of cesarean birth related with FHR problem
PROCEDURE
The amnio infusion procedure involves the use of an intrauterine pressure catheter (IUPC), or a single or double lumen type of IUPC.
The IUPC has been designed to attain an accurate monitoring of uterine contractions among women in the intrapartum period.
It has a special port from which the saline fluid or lactated ringer’s solution is being injected, passing through the tubing and going its way into the uterus.
An IUPC is inserted through standard technique once the membranes ruptures, and then it is attached to intravenous extension tubing. If IUPC is not available, a pediatric nasogastric tube can be used instead.
Lactated ringer’s solution without dextrose is infused into the amniotic cavity; normal saline can be an acceptable fluid alternative
Assisting Physician with Amnioinfusion
Explain the procedure to the patient.
Assist in dorsal recumbent position. Assist with draping and exposing vaginal area.
Connect IUPC tubing to IV fluid, flush
Connect the catheter to the monitor cable
Assist physician with insertion of double lumen IUPC and connect IV tubing to the amnioport to begin amnioinfusion.
Oligohydramnios by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
• Oligohydramnios refers to amniotic fluid volume that is less than expected for gestational age. It is typically diagnosed by ultrasound examination and may be described qualitatively (eg, reduced amniotic fluid volume) or quantitatively (eg, amniotic fluid index ≤5 cm, single deepest pocket <2 cm).
• Oligohydramnios may be idiopathic or have a maternal, fetal, or placental cause The fetal prognosis depends on several factors, including the underlying cause, the severity (reduced versus no amniotic fluid), and the gestational age at which oligohydramnios occurs. Because an adequate volume of amniotic fluid is critical to normal fetal movement and lung development and for cushioning the fetus and umbilical cord from uterine compression, pregnancies complicated by oligohydramnios from any cause are at risk for fetal deformation, pulmonary hypoplasia, and umbilical cord compression.
• Oligohydramnios is associated with an increased risk for fetal or neonatal death, which may be related to the underlying cause of the reduced amniotic fluid volume or due to sequelae of the reduced amniotic fluid volume.
• This topic will discuss issues related to oligohydramnios. Methods of amniotic fluid volume assessment are reviewed separately.
• Oligohydramnios occurs when the amniotic fluid is < 5th centile for gestational age.
• The most common causes are premature rupture of membranes (often missed by the mother) and placental insufficiency, however structural abnormalities such as renal agenesis should be considered.
• Prognosis is linked to gestation at diagnosis and likely development of pulmonary hypoplasia and premature delivery.
• Treatment is by optimising gestation of delivery
This topic contains anticonvulsants used in obstetrics such as magnasium sulphate, diazepam, phenytoin and anticoagulants such as heparin and warfarin.
Eclampsia is conclusive and convulsive phase of a wide spectrum disease pre eclampsia. More conclusive RCT are required to assert the efficacy of biomarkers as a sensitive predictability of eclampsia.
A 38 slide power-point presentation for medical students years 4 or 5. The idea to familiarize with classification, clinical features, diagnosis and management.
Anemia in pregnancy &role of parenteral iron therapysusanta12
Iron deficiency anemia is most common anemia during pregnancy whic needs careful evaluation and treatment by Dr Susanta Kumar Behera,Department of Obstetrics & Gynecology, MKCG Medical College, Brahmapur,ODISHA,INDIA
Symtomatic urinary tract infections during pregnancysusanta12
As UTI forms one of the most common complications during pregnancy leading to poor fetomaternal outcome, it should be evaluated and treated early in the course of pregnancy so as to avoid the complications of preterm birth, IUGR, IUD etc
it cinstitutes the most common form of complications encountered in eclampsia. it is potentialy curable if diagnosed and treated early in course. this is the state of affairs in MKCG Medical College, Berhampur, ODISHA, INDIA
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
1. MANAGEMENT OF ECLAMPSIA
Subudhi Khetrabasi,Behera Susanta Kumar,Subudhi Monalisa,Das Sudhansu Kumar,Jena Soubhagya
Kumar
INTRODUCTION
Eclampsia is development of convulsions and/or unexplained coma during pregnancy or
postpartum in patients with signs and symptoms of preeclampsia, 2 nd most common cause of
seizure during pregnancy. It is common in primigravida. In 80% cases it is preceded by severe
preeclampsia between 36th weeks to term. It can be antepartum (50%), intrapartum (30%),
postpartum (20%).
PATHOGENESIS
It is state of a triad consisting of hypertension, proteinuria > 300 mg/24 hr urine
output and convulsion. The underlying basic pathology is intense vasospasm and endothelial
dysfunction. Causes of convulsion includes (a) Cerebral anoxia due to spasm of cerebral vessel
because of increase cerebrovascular resistance-decrease oxygen consumption (b) Cerebral
irritation (c) Cerebral dysarhythmia .
CLINICAL FEATURE
. It progresses through four stages as follows as premonitory starting with twitching,
tonic spasm of body, ceasing of respiration, protruding of tongue and fixing of eye ball, clonic
phase of alternate contraction & relaxation of muscle, congested face & cyanosed, conjunctival
congestion, twitching starting from face & spreading tongue biting, stertourous breathing with
froths and involuntary passage of stool & urine and finally coma which persists for variable
period. Labor usually starts shortly after the fit. Common symptoms includes headache, edema,
visual disturbance, fits, anxiety, amnesia, abdominal Pain, decreased urine output or none,
tachycardia and tachypnoea, creps or wheeze, petechiae, generalised oedema, small uterus for
dates. 1
DIFFERENTIAL DIAGNOSIS
a) With Convulsions : Epilepsy, Cerebral Malaria, Hysteria, Meningitis and Encephalitis,
Tetanus, Strychnine poisoning, Brain tumors, Uremic convulsions b) With Coma:
Hypoglycemia, Hyperglycemic coma, Uremic coma, Hepatic coma, Alcoholic coma,
cerebral coma.
INVESTIGATIONS
• Routine : Hemoglobin, DC, TLC, TPC, BT/CT, Urine (R & M) and Protein, LFT, RFT,
Serum Uric acid, ECG, FBS, ophthalmoscopy, obstetric USG Scan.
1
2. • Special : BPP, CT, CTG, Coagulation Profile, Color Doppler, MRI, electrolytes.2
MANAGEMENT
It consists of general care, control of convulsions, blood pressure, obstetric management,
management of complications including prevention and postpartum Care. General : Consists of
placing the patient in a railed cot in isolated room with raising the foot end of bed, followed by
detailed history taking, continuous draining of urine, monitoring vitals & urine output, tracheo-
bronchial suction and IV 25% Glucose.
Control of Convulsion : convulsions are controlled by different agents in different
scheduled as follows 1) Magnesium Sulphate : Continuous IV Regimen, Pitchard Regimen,
Sibai Regimen, Zuspan Regimen 2) Diazepam 3) Phenytoin 4) Lytic Cocktail Regimen :
Chlorpromazine, Promethazine, Pethidine.
Magnesium Sulphate can be given as IV or IM and SC as 15 % (SC), 20- 25% (IV) and
50% (IM) solution. Monitoring of toxicity can be done by absence of patellar reflex, respiratory
rate < 16/min, urine output < 80-100ml/hr and serum magnesium level. 3 Specific Antidote – 10
ml of 10% Calcium Gluconate slow IV given. Magnesium level in increasing concentration
produces following effects as depicted in table-I.
Table-I
Manifestation Serum Level
Clinical
Therapeutic 4-7 mEq/L
Arrest of Deep Reflex 8-12 mEq/L
Respiratory Arrest 13-19 mEq/L
Cardiac Arrest > 20 m Eq/L
CONTINUOUS IV REGIMEN: 4-6 gm loading dose of mg So4 in 100 ml of fluid IV
slowly over 15-20 min followed by 1-2gm/hr in 100 ml of IV maintenance infusion.
PRITCHARD REGIMEN : 4 gm of 25% mgso4 IV slowly over 5-10 min followed by 5 gm
50% mgso4 IM into each buttock followed by 5 gm 50% mgso4 IM 4hrly to alternate buttock.
SIBAI REGIMEN: 6 gm MgSo4 over 20 min followed by 2 gm MgSO4 IV infusion. ZUSPAN
REGIMEN: 4 gm MgSo4 over 5-10 min followed by 1gm/hr MgSO4 IV infusion.
• DIAZEPAM: 10-40 mg IV slowly followed by 40 mg in 500 ml of 5%D at the rate of
30 drops/min
3. LYTIC COCKTAIL REGIMEN: Menon in India has started this regimen-1961 which
consists of 25 mg chlorpromazine & 100 mg pethidine in 20 ml of 5%D IV + 50 mg
chlorpromazine & 25 mg promethazine IM, followed by 50 mg chlorpromazine & 25 mg
promethazine IM alternatively 4 hrly X 24 hr. IV drip 10% dextrose with 100 mg
pethidine at rate of 20-30 drop/min for 24 hr following last fit.
PHENYTOIN : 10 mg/kg slow IV followed by 5 mg/kg after 2 hr followed by 200 mg
given orally after 12 hrs X 48 hrs following delivery.4
Status Eclampticus: Medications like Inj Thiopentone Sodium 0.5 mg in 20 ml of 5D IV
slowly. If failed general anesthesia is administered.
Fluid therapy: It is significant as cause iatrogenic fluid overload is the main cause of
maternal death in eclampsia. Principle includes 1) accurate recording of input output deficit 2)
Crystalloids is the choice of fluid(Ringer Lactate), total daily infusion should be UO+1000 ml or
80ml/hr. Antihypertensives are indicated if BP > 160/110 mm of Hg in spite of anticonvulsants &
sedatives. Common drugs used are Labetalol, Nifedipine, and Methyl Dopa(table-II).5
Table-II
Agent Dose Max Dose
: 100 mg 12 hrly
Oral Oral : 2400 mg
Labetalol
repeat 40-80 mg every 10 min IV : 300 mg
IV : 20 mg &
Nifedipine Oral :10 mg 6-8 hrly 120 mg
Methyldopa Oral : 250 mg 8 hrly 2 gm
Obstetric management: Delivery is the cure for eclampsia and pregnancy is terminated
within 6-8 hrs of hospitalization and decision taken depending on fetal maturity, gestational age,
liquor volume and cervical status. If the woman is presented in labour, ARM to be done followed
by augmentation by oxytocin and delivery by vaccum or forceps. If the woman is not in labor,
induction is done by prostaglandin gel or tablet, ARM and delivery. Caesarian section is
indicated in presence of obstetric conditions like preterm baby, IUGR, Malpresentation,
abruption placentae. No use of prophylactic methyl-egrometrine/Syntometrine, and prophylactic
rectal misoprostol. Third Stage of labor is managed by 5-10 units of IV oxytocin or IM
prostaglandin.6 Epidural is the choice of anesthesia due to provocation of excessive hypotension,
superior pain relief, and promotion of uteroplacental blood flow. It can be extended to provide
regional anesthesia for instrumental delivery or caesarian section.Common complications
encuntered are (i) Maternal : Renal failure, ARDS, pulmonary edema, HELLP Syndrome, DIC,
cerebral hemorrhage, cortical blindness, Abruptio Placentae or PPH (ii) Fetal : IUGR and
3
4. premature delivery and managed according to etiopathogenesis.MgSo4 is administered i.e 24 hr
of delivery/last Seizure. Recurrence risk is 30-70%. 7
Preventing eclampsia may be primary, secondary or tertiary. Primary prevention includes
prevention of development of preeclampsia i.e. folic acid, fish oil and periodic screening.
Secondary prevention includes pharmacological agents to prevent convulsion in preeclampsia i.e.
low dose aspirin, magnesium sulphate, etc. Tertiary prevention includes prevention of subsequent
convulsion in established eclampsia.8
REFERENCES
1) F Garry Cunning Ha, C Gilstrap et al. Hypertensive disorders of pregnancy;Williams
Obstetrics. 22nd Edition; 2005; Ch-34; P-783-784.
2) Chesley L C et al. Hypertensive Disorders of Pregnancy. New York; Appleton-Century
Crofts, 2008:1:2.
3) Data M R .Magnesium in eclampsia : A Safe and effective approach. J Obste Gynecol
India 2002;52(3).
4) Lucas M J. A comparision of magnesium sulphate with phenytoin for the prevention of
eclampsia. N Eng. J Med 2005; 333:201-05.
5) Mennon M K. The Evolution of treatment of Eclampsia. J Oph Soc Am.2001; 68:417.
6) Sibai B M. Diagnosis, prevention and management of Eclampsia. J. Obste Gynecol 2005
Feb; 105(2):402-10.
7) Polley L S. Anesthetic Management of hypertension in pregnancy. Clin Obste Gynecol
2003 Sept; 46(3):688-99.
8) Dekker G.Primary, Secondary and tertiary prevention of Preeclampsia. Lancet
2001;51(4):32